BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20569422)

  • 1. Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques.
    Lapins M; Wikberg JE
    BMC Bioinformatics; 2010 Jun; 11():339. PubMed ID: 20569422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinome-Wide Profiling Prediction of Small Molecules.
    Sorgenfrei FA; Fulle S; Merget B
    ChemMedChem; 2018 Mar; 13(6):495-499. PubMed ID: 28544552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided selection of specificity determining positions in the human Kinome.
    Moll M; Finn PW; Kavraki LE
    BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):431. PubMed ID: 27556159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale proteomics analysis of the human kinome.
    Oppermann FS; Gnad F; Olsen JV; Hornberger R; Greff Z; Kéri G; Mann M; Daub H
    Mol Cell Proteomics; 2009 Jul; 8(7):1751-64. PubMed ID: 19369195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Proteometric Analysis of Human Kinome: Insight into Discriminant Conformation-dependent Residues.
    Bosc N; Wroblowski B; Aci-Sèche S; Meyer C; Bonnet P
    ACS Chem Biol; 2015 Dec; 10(12):2827-40. PubMed ID: 26411811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visually interpretable models of kinase selectivity related features derived from field-based proteochemometrics.
    Subramanian V; Prusis P; Pietilä LO; Xhaard H; Wohlfahrt G
    J Chem Inf Model; 2013 Nov; 53(11):3021-30. PubMed ID: 24116714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human kinome and kinase inhibition.
    Duong-Ly KC; Peterson JR
    Curr Protoc Pharmacol; 2013 Mar; Chapter 2():Unit2.9. PubMed ID: 23456613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The resistance tetrad: amino acid hotspots for kinome-wide exploitation of drug-resistant protein kinase alleles.
    Bailey FP; Andreev VI; Eyers PA
    Methods Enzymol; 2014; 548():117-46. PubMed ID: 25399644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Kinase Interaction Networks: A New Paradigm in PPI Based Design of Kinase Inhibitors.
    Jenardhanan P; Panneerselvam M; Mathur PP
    Curr Top Med Chem; 2019; 19(6):467-485. PubMed ID: 31184298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building and exploring an integrated human kinase network: global organization and medical entry points.
    Colinge J; César-Razquin A; Huber K; Breitwieser FP; Májek P; Superti-Furga G
    J Proteomics; 2014 Jul; 107(100):113-27. PubMed ID: 24704859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Profiling and Evaluation of Structure-based Kinase-Inhibitor Interactome in Cervical Cancer by Integrating In Silico Analyses and In Vitro Assays at Molecular and Cellular Levels.
    Zhu LX; Liu Q; Hua YF; Yang N; Zhang XG; Ding X
    Comput Biol Chem; 2019 Jun; 80():324-332. PubMed ID: 31078911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of kinase inhibitor selectivity.
    Davis MI; Hunt JP; Herrgard S; Ciceri P; Wodicka LM; Pallares G; Hocker M; Treiber DK; Zarrinkar PP
    Nat Biotechnol; 2011 Oct; 29(11):1046-51. PubMed ID: 22037378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification Studies.
    Ravikumar B; Timonen S; Alam Z; Parri E; Wennerberg K; Aittokallio T
    Cell Chem Biol; 2019 Nov; 26(11):1608-1622.e6. PubMed ID: 31521622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?
    Christmann-Franck S; van Westen GJ; Papadatos G; Beltran Escudie F; Roberts A; Overington JP; Domine D
    J Chem Inf Model; 2016 Sep; 56(9):1654-75. PubMed ID: 27482722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid computational identification of the targets of protein kinase inhibitors.
    Rockey WM; Elcock AH
    J Med Chem; 2005 Jun; 48(12):4138-52. PubMed ID: 15943486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery.
    Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S
    J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting kinase profiling data to predict activity and understand cross-reactivity of kinase inhibitors.
    Niijima S; Shiraishi A; Okuno Y
    J Chem Inf Model; 2012 Apr; 52(4):901-12. PubMed ID: 22414491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.